Suraj B. Sable

932 total citations
20 papers, 735 citations indexed

About

Suraj B. Sable is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Suraj B. Sable has authored 20 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 11 papers in Immunology and 8 papers in Epidemiology. Recurrent topics in Suraj B. Sable's work include Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (6 papers) and vaccines and immunoinformatics approaches (5 papers). Suraj B. Sable is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Mycobacterium research and diagnosis (6 papers) and vaccines and immunoinformatics approaches (5 papers). Suraj B. Sable collaborates with scholars based in United States, India and Uganda. Suraj B. Sable's co-authors include G. K. Khuller, Indu Verma, James E. Posey, Gareth Griffiths, Bo Nyström, Subhadra Nandakumar, Thomas J. Scriba, Rama Rao Amara, Mamta Kalra and Kathryn L. Kellar and has published in prestigious journals such as PLoS ONE, Nature Reviews Microbiology and Clinical Microbiology Reviews.

In The Last Decade

Suraj B. Sable

20 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suraj B. Sable United States 17 423 317 259 206 106 20 735
Samira Mansouri United States 10 183 0.4× 592 1.9× 121 0.5× 309 1.5× 69 0.7× 23 877
Hedvika Lazar Switzerland 13 148 0.3× 202 0.6× 252 1.0× 260 1.3× 34 0.3× 18 768
Tjarko Meijerhof Netherlands 18 234 0.6× 333 1.1× 431 1.7× 183 0.9× 35 0.3× 25 807
Fatme Mawas United Kingdom 17 127 0.3× 121 0.4× 267 1.0× 159 0.8× 54 0.5× 37 664
Kate M. O’Keeffe Ireland 8 283 0.7× 354 1.1× 101 0.4× 228 1.1× 10 0.1× 8 656
Sandra I. Aguiar Portugal 19 96 0.2× 120 0.4× 483 1.9× 265 1.3× 58 0.5× 36 1.1k
Alison G. Murphy Ireland 7 195 0.5× 327 1.0× 95 0.4× 182 0.9× 9 0.1× 7 571
Anne Marit de Groot Netherlands 12 98 0.2× 119 0.4× 68 0.3× 216 1.0× 77 0.7× 14 453
Maria Hottelet Foley United States 5 174 0.4× 409 1.3× 70 0.3× 226 1.1× 54 0.5× 5 645
Hanne Schoenen Germany 7 253 0.6× 574 1.8× 271 1.0× 252 1.2× 12 0.1× 7 892

Countries citing papers authored by Suraj B. Sable

Since Specialization
Citations

This map shows the geographic impact of Suraj B. Sable's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suraj B. Sable with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suraj B. Sable more than expected).

Fields of papers citing papers by Suraj B. Sable

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suraj B. Sable. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suraj B. Sable. The network helps show where Suraj B. Sable may publish in the future.

Co-authorship network of co-authors of Suraj B. Sable

This figure shows the co-authorship network connecting the top 25 collaborators of Suraj B. Sable. A scholar is included among the top collaborators of Suraj B. Sable based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suraj B. Sable. Suraj B. Sable is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sable, Suraj B., James E. Posey, & Thomas J. Scriba. (2019). Tuberculosis Vaccine Development: Progress in Clinical Evaluation. Clinical Microbiology Reviews. 33(1). 77 indexed citations
2.
Nandakumar, Subhadra, Sunil Kannanganat, Karen M. Dobos, et al.. (2016). Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis. Scientific Reports. 6(1). 25837–25837. 17 indexed citations
3.
Nandakumar, Subhadra, Sunil Kannanganat, James E. Posey, Rama Rao Amara, & Suraj B. Sable. (2014). Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice. PLoS ONE. 9(11). e113951–e113951. 33 indexed citations
4.
Nandakumar, Subhadra, Sunil Kannanganat, Karen M. Dobos, et al.. (2013). O-mannosylation of the Mycobacterium tuberculosis Adhesin Apa Is Crucial for T Cell Antigenicity during Infection but Is Expendable for Protection. PLoS Pathogens. 9(10). e1003705–e1003705. 31 indexed citations
5.
Sable, Suraj B., Subhadra Nandakumar, Sunita Sharma, et al.. (2011). Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination. PLoS ONE. 6(7). e22718–e22718. 28 indexed citations
6.
Nandakumar, Subhadra, Seong‐O Choi, Jeong Woo Lee, et al.. (2011). Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine. 29(14). 2626–2636. 81 indexed citations
7.
Sow, Fatoumata B., Subhadra Nandakumar, Vijayakumar Velu, et al.. (2011). Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis. 91(4). 314–321. 53 indexed citations
8.
Griffiths, Gareth, Bo Nyström, Suraj B. Sable, & G. K. Khuller. (2010). Nanobead-based interventions for the treatment and prevention of tuberculosis. Nature Reviews Microbiology. 8(11). 827–834. 123 indexed citations
9.
Sow, Fatoumata B., Suraj B. Sable, Bonnie B. Plikaytis, William P. Lafuse, & Thomas M. Shinnick. (2008). Role of Hepcidin in the Innate Immune Response to Mycobacterium tuberculosis. The FASEB Journal. 22(S2). 556–556. 2 indexed citations
10.
Kalra, Mamta, Ajay Grover, Jaspreet Singh, et al.. (2007). Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice. Clinical Immunology. 125(2). 173–183. 28 indexed citations
11.
Sable, Suraj B., Mamta Kalra, Indu Verma, & G. K. Khuller. (2007). Tuberculosis subunit vaccine design: The conflict of antigenicity and immunogenicity. Clinical Immunology. 122(3). 239–251. 38 indexed citations
12.
Birkness, K A, Jeannette Guarner, Suraj B. Sable, et al.. (2007). An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection. Immunology and Cell Biology. 85(2). 160–168. 51 indexed citations
13.
Sable, Suraj B., et al.. (2006). Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. European Respiratory Journal. 29(2). 337–346. 16 indexed citations
14.
Sable, Suraj B., Bonnie B. Plikaytis, & Thomas M. Shinnick. (2006). Tuberculosis subunit vaccine development: Impact of physicochemical properties of mycobacterial test antigens. Vaccine. 25(9). 1553–1566. 16 indexed citations
15.
Sable, Suraj B., Indu Verma, & G. K. Khuller. (2005). Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. Vaccine. 23(32). 4175–4184. 39 indexed citations
16.
Sable, Suraj B., et al.. (2005). Human immune recognition-based multicomponent subunit vaccines against tuberculosis. European Respiratory Journal. 25(5). 902–910. 18 indexed citations
17.
Giri, Pramod, Suraj B. Sable, Indu Verma, & G. K. Khuller. (2005). Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis. FEMS Immunology & Medical Microbiology. 45(1). 87–93. 44 indexed citations
18.
Sable, Suraj B., Mamta Kalra, Indu Verma, et al.. (2005). Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis. Infection and Immunity. 73(6). 3547–3558. 33 indexed citations
19.
Sable, Suraj B., Sukhwinder Kaur, Indu Verma, & G. K. Khuller. (2005). Immunodominance of low molecular weight secretory polypeptides of Mycobacterium tuberculosis to induce cytotoxic T-lymphocyte response. Vaccine. 23(41). 4947–4954. 6 indexed citations
20.
Sable, Suraj B., Rajnish Kumar, Mamta Kalra, et al.. (2005). Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis. Infection and Immunity. 73(12). 8456–8456. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026